MoneyWorks4Me

Dishman Carbogen Amcis raises Rs 50 crore through NCDs

20 Jan 2026 Evaluate

Dishman Carbogen Amcis has raised Rs 50 crore through the allotment of 5,000 Senior, Secured, Rated, Listed, Transferable, Taxable, Redeemable Non-Convertible Debentures (NCDs) of Rs 1,00,000 each at par for cash, on private placement basis. The Management Committee of Board of Directors has at its meeting held on January 20, 2026 approved allotment of the same.

Dishman Carbogen Amcis (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators. 


Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..